Oncology
Inherited Diseases
Preventive Genomics
Infectious Diseases

Prescribe with confidence

from the genome you already sequenced.

Pharmacogenomics is the first module of SeqOne Preventive Genomics. It turns your panels, exomes and genomes into star-allele diplotypes, phenotypes and guideline-backed drug recommendations, inside GermVar.

Carrier screening and newborn screening are next in Preventive Genomics.
Stay informed →

Right drug. Right dose. Right patient.

Turn every germline analysis into prescribing guidance.

Call star alleles, including CYP2D6 copy number and hybrid alleles

Score every call from coverage, fit and separation before you sign

Compare CPIC, DPWG, FDA and RNPGx guidance side by side, drug by drug

Generate a PGx passport with key findings on page one, in your lab's colors

99.5%
of people carry at least one diplotype linked to a non-typical drug response¹
–30%
clinically relevant adverse drug reactions with a pre-emptive 12-gene PGx panel²
5%
of hospital admissions in the EU are caused by adverse drug reactions³

Pharmacogenomics is easy to order and hard to get right. CYP2D6 hides deletions, duplications and hybrids. CPIC and DPWG do not always agree. And PGx is often a second test on a sample you have already sequenced. SeqOne brings genotyping, evidence and reporting into the germline workflow your lab already runs.

Book a demo

1. McInnes et al., Pharmacogenetics at scale: an analysis of the UK Biobank, 2021. 2. Swen et al., PREPARE trial, The Lancet, 2023. 3. European Commission estimate, 2008.

With this module, SeqOne has finally brought our two worlds together: pharmacology and genetics. In a few clicks we can check our analysis metrics and get everything we need on the variants found. Then, without switching environment or tool, we explore the pharmacological recommendations that apply and format them for clinicians.

End-to-end pharmacogenomics in one platform.

Genotyping

Star alleles
Copy number
CYP2D6/2D7 hybrids
Phasing
HLA-A / HLA-B
Activity score
Novel allele warning
Confidence score on every diplotype

Guideline sources

CPIC
DPWG
FDA
RNPGx
PharmGKB
Your lab
Your source order, your rules

Interpretation

D · Avoid
C · Adjust
B · Monitor
A · Standard
Drug or brand search
Therapeutic area
Evidence level

Panels

PGx and germline capture panels

WES

Clinical exome to whole exome

WGS

Whole genome sequencing

Coverage

56
pharmacogenes
1,400+
alleles defined
160+
drugs with guidance
5,000+
recommendations
Download the gene coverage (PDF) →

Reporting

PGx passport
Clinical summary
Gene summary
Drug guidance
Quality & method
Your branding
Reviewer approval

One sample, two answers.

Your diagnostic run is also a PGx test.

The PGx module runs inside GermVar, on the same FASTQ files as your germline analysis. No new sample, no second assay, no extra pipeline to validate.

Green check

Panels, exomes and genomes

Green check

PGx next to QC, coverage and variants in the same analysis

Green check

One profile per patient, reusable for every future prescription

One germline sequencing run producing both the genetic report and the PGx report

From reads to recommendations.

Discover the GermVar PGx module.

CYP2D6 haplotype view with both alleles, their variants and the diplotype confidence

Genotyping you can review

Each gene opens on its diplotype, phenotype and the function of both alleles, with the variants behind every haplotype.

Diplotype

Star alleles, phenotype, CPIC activity score

Structural alleles

CYP2D6 deletions, duplications and hybrids such as *4+*68

Haplotype view

Missense, loss-of-function and non-coding variants per allele

Confidence

Coverage, fit and separation, with novel-allele warnings
Guideline engine comparing CPIC, DPWG, FDA and RNPGx recommendations for one drug

Every guideline, in your order

International and European sources side by side, so each lab reports the guidance its clinicians follow.

Sources

CPIC, DPWG, FDA, RNPGx and 7 more national guidelines

Lab knowledge

Your rules first, public guidance after, or yours only

Impact levels

A Standard, B Monitor, C Adjust, D Avoid

Traceability

Source, classification, population and guideline link on every recommendation
Preemptive PGx passport report with the clinical summary on page one

A PGx passport for life

The Preemptive PGx Passport covers a broad set of genes and drugs with published guidance, a reference to support future prescribing decisions.

Clinical summary

Drugs to avoid and drugs to adjust on page one

Gene summary

Diplotypes, phenotypes, activity scores and confidence

Drug guidance

Grouped by therapeutic area

Your brand

Logo, accent color, quality metrics and approval

Across specialties.

The gene–drug pairs that change prescriptions.

Oncology

DPYD · UGT1A1 · TPMT · NUDT15

Fluoropyrimidines, irinotecan and thiopurines, where a missed variant can cause severe toxicity.

Cardiology

CYP2C19 · SLCO1B1 · CYP2C9 · VKORC1

Clopidogrel, statins and vitamin K antagonists such as warfarin, acenocoumarol and fluindione.

Psychiatry and pain

CYP2D6 · CYP2C19 · CYP2B6

Antidepressants, codeine and tramadol, where metabolizer status changes efficacy and safety.

Anesthesia

RYR1 · CACNA1S

Volatile anesthetics and succinylcholine in patients at risk of malignant hyperthermia.

Drug hypersensitivity

HLA-B*57:01 · HLA-B*15:02 · HLA-A*31:01 · HLA-B*58:01

Abacavir, carbamazepine and allopurinol, where one HLA allele can predict a severe reaction.

Infectious disease

MT-RNR1 · G6PD · NAT2

Aminoglycoside-induced hearing loss, primaquine and isoniazid.

Why SeqOne.

What makes our solution different.

Diagnosis and PGx in one platform

The same analysis, QC and team review rare-disease variants and drug response.

Built for the hard genes

Copy number, hybrids and phasing are part of the call, and every call carries its confidence.

Global guidance, local priorities

CPIC and FDA sit next to DPWG, RNPGx, CPNDS, AusNZ and other national guidelines, so your lab follows the sources that apply where you practice.

Transparent evidence

Every recommendation shows where it comes from. No black box.

Your rules, your report

Add lab knowledge, set the source order and brand the report with your colors.

A versioned knowledge base

Each release is dated, so every report records the knowledge it used.

More than a platform.

Your lab, our commitment.

Built with you

Validate the PGx module on your own samples, with expert support and zero commitment.

Transparent, flexible pricing

Pay per analysis, with no hidden fees or volume constraints.

Personalized support

Field specialists and multilingual help, from validation to your first signed report.

Try it now

Frequently asked questions

Which sequencing data can I use?

For now, SeqOne PGx supports short-read sequencing only: data from targeted gene panels, whole exomes and whole genomes, aligned to GRCh38. Long-read data is not supported yet. The module starts from the FASTQ files of your GermVar analysis, so there is no separate assay or pipeline to run. For a panel, the pharmacogenes you want to report must be in the capture design; we check this with you during setup.

How is PGx priced?

PGx is included at no additional cost with WES and WGS analyses launched in GermVar. You get the drug-response profile from the same sequencing and analysis you already run for the diagnosis, with no new sample or assay. For targeted panels and other setups, your SeqOne contact will find the right option for your lab.

Which genes and drugs are covered?

56 pharmacogenes plus HLA-A, -B and -C typing, more than 1,400 alleles with curated function and more than 160 drugs with recommendations from 11 sources: CPIC, DPWG, FDA, RNPGx, CPNDS, SEFF/SEOM, AIOM, AHA, ACR, CFF and AusNZ.

How accurate is it?

We validated the module on 56 samples against 4 reference truth sets: 98.9% genotype concordance, 99.2% phenotype concordance and 100% recall of the expected drug recommendations, above our 95% acceptance criterion. The validation summary is available on request.

How do you handle difficult genes like CYP2D6?

Copy number is estimated from sequencing depth first and used to constrain the allele search, so deletions, duplications and CYP2D6/CYP2D7 hybrid alleles are part of the call. Every diplotype comes with quality scores, and warnings are raised in plain view, for example when a novel major allele is detected.

Can I check the evidence behind each call?

Yes. Click a gene in the PGx tab to see its quality scores, each variant phased on its allele, and the underlying calls with genotype, depth and VAF, with a link into the variant viewer. Nothing is hidden: you review the call before it reaches the report.

Can I choose what goes into the report?

Yes. Before issuing, you choose the report type (a clinical report or a pre-emptive PGx passport), the genes and drugs reported, the guideline sources and their order, and the impact levels shown. The report carries your logo and colors, is signed in the platform and records the knowledge-base version used.

Can I add my laboratory's own recommendations?

Yes. Add lab knowledge and choose whether it comes before public guidance or replaces it.

Does it change my existing GermVar analyses?

No. PGx is an option you pick when launching an analysis. You keep QC, gene coverage and the variant viewers, and get a PGx tab on top, so one run can give both the genetic report and the PGx report. Analyses launched without the option run exactly as before.

Is patient data sent to external services?

No. The PGx knowledge base runs inside the platform, and no third-party service is called during the analysis. The knowledge base is versioned and its version is stamped on every result.

Can I use genotyping arrays or DRAGEN results?

This is on our roadmap: results from Thermo Fisher OpenArray, Agena MassARRAY, Pleno and DRAGEN will feed the same PGx tables and reports.